Status:
UNKNOWN
Hepatitis B en Haitian Immigrants in Chile: Molecular Characterization and Determination of Vaccine Response
Lead Sponsor:
Pontificia Universidad Catolica de Chile
Conditions:
Hepatitis B
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
International migration to Chile has sharply increased since 2010. Particularly, Haitian migration now totals approximately 200.000 people. Preliminary results show a high prevalence of hepatitis B in...
Detailed Description
Migration from Haiti to Chile has increased exponentially in the last years. More than 200.000 people from this island are currently living in Chile. Preliminary results of the investigators group sho...
Eligibility Criteria
Inclusion
- Adults (\> 18 yo) born in Haiti.
- Living in Chile (and planning to stay in Santiago for the next 4 months).
Exclusion
- Not signing the informed consent.
- Pregnancy.
- HIV or HCV infection.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04326803
Start Date
June 1 2020
End Date
December 30 2023
Last Update
March 31 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.